Skip to content

Insider · CIK 0001861684

Joseph R Young

officer

Files at VERA (Vera Therapeutics, Inc.). First filing Nov 13, 2025, latest Nov 13, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $436k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

VERA: Vera Therapeutics, Inc.

VERAOct 9, 2026 · close 29.88

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
30Weak
VERAsell 2
Vera Therapeutics, Inc.
$436k
15,000 shares
-24%+58% from low-40% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026VERA
Vera Therapeutics, Inc.
MOption exercise
Class A Common Stock
+5,000$3.94$20k80,75428 d ago
Sep 11, 2026VERA
Vera Therapeutics, Inc.
MOption exercise
Stock Option (right to buy)derivative
-5,000$0.00$033,58928 d ago
Nov 11, 2025VERA
Vera Therapeutics, Inc.
SOpen-market sale
Class A Common Stock
-15,000$29.06$436k47,839Nov 13, 2025
Nov 13, 2025VERA
Vera Therapeutics, Inc.
MOption exercise
Class A Common Stock
+10,000$3.94$39k57,839Nov 13, 2025
Nov 13, 2025VERA
Vera Therapeutics, Inc.
MOption exercise
Stock Option (right to buy)derivative
-10,000$0.00$048,589Nov 13, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Joseph R Young: insider trades and track record | InsiderTell